Evidence map›Paper›PMID 40284506›Full record

ArticlePharmaceutics2025

Amphiphilic Celecoxib-Polysaccharide Delivery System for Enhanced Colon-Targeted Colitis Therapy.

Qiao Qiao, Xian Wan, Jie Li, Weijun Chen, Enxuan Li, Lipeng Qiu, Huiming Tu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qiao QiaoDepartment of Gastroenterology, Affiliated Hospital of Jiangnan University, Wuxi 214122, China.
Xian WanSchool of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China.
Jie LiSchool of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China.
Weijun ChenSchool of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China.
Enxuan LiThe Second Clinical Medical School, Nanjing Medical University, Nanjing 210029, China.
Lipeng QiuSchool of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China.ORCID 0000-0001-7546-7420
Huiming TuDepartment of Gastroenterology, Affiliated Hospital of Jiangnan University, Wuxi 214122, China.

Funding

National Key Research and Development Program of China 2021YFC2103100
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

celecoxibchondroitin sulfatedrug deliveryulcerative colitis

Identifiers

PMID40284506
PMCPMC12030041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.